LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
Clinical trials for LOCALLY ADVANCED NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 19:12 UTC
-
Smart radiation tailored to each tumor could extend lung cancer survival
Disease control Recruiting nowThis study tests a new approach to radiation therapy for people with stage III lung cancer that cannot be removed by surgery. The treatment uses a special technology called RAPART to personalize the radiation dose based on how sensitive each person's tumor is to radiation. The go…
Matched conditions: LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated May 16, 2026 19:10 UTC
-
New combo targets lung tumors without chemo or surgery
Disease control Recruiting nowThis study tests a drug called NBTXR3 given with radiation therapy for people with advanced non-small cell lung cancer who cannot have chemotherapy or surgery. The goal is to see if the combination is safe and helps control the cancer. About 40 adults with stage I to III lung can…
Matched conditions: LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC